Filtered By:
Source: Mass Device
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 467 results found since Jan 2013.
MassDevice.com +5 | The top 5 medtech stories for May 12, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Xtant Medical amends Orbimed credit line to $15m, taps restructuring advisors
Xtant Medical said today that it amended its senior credit line with OrbiMed Advisors, saying it plans to use the $15 million facility to pay off the ...
Source: Mass Device - May 12, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Boston Scientific touts 1-year stroke reduction results in Watchman non-valvular AF trial
Boston Scientific (NYSE:BSX) today released 1-year results from the Ewolution registry study of its Watchman left atrial appendage closure device, touting a high implant success rate and stroke reduction in patients with non-valvular atrial fibrillation patients.
Data was presented today at the Heart Rhythm Society’s 39th Annual Scientific Sessions in Chicago.
“We are pleased to see that these ‘real-world’ results reinforce the positive outcomes observed in our clinical trial program, despite the registry patients being older and sicker than those enrolled in our previous trials,” rhythm man...
Source: Mass Device - May 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news
Cleveland Clinic, Boston Sci think deep brain stimulation can treat strokes
Illustration of a deep brain stimulation lead implanted in the cerebellar dentate nucleus for treatment of post-stroke motor deficits. [Image from Cleveland Clinic]The Cleveland Clinic is pioneering deep brain stimulation for stroke recovery, with an ongoing clinical trial to determine if Boston Scientific’s Vercise DBS system improves movement in recovering stroke patients.
Dr. Andre Machado and his team performed the 6-hour deep brain stimulation surgery on Dec. 19, 2016. The procedure implanted electrodes into the cerebellum section of the brain. The deep brain stimulation electrodes emit small electric pulses while c...
Source: Mass Device - May 9, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Biotech Neuromodulation/Neurostimulation Boston Scientific Cleveland Clinic deep brain stimulation MedTech Source Type: news
Abbott wins CE Mark for Confirm Rx cardiac monitor
Abbott (NYSE:ABT) said today that its St. Jude Medical (NYSE:STJ) subsidiary won CE Mark approval in the European Union for the ConfirmRx insertable cardiac monitor, touting as the world’s 1st smartphone-compatible ICM.
The continuous heart monitor is designed to work with St. Jude’s myMerlin mobile app to allow physicians to remotely follow patients and diagnose arrhythmias. Abbott said it’s on the market in 10 “select” countries in Europe, with a full release slated for the 2nd quarter. The FDA is also reviewing the device, the Chicago-area healthcare giant said.
“Incorporating w...
Source: Mass Device - May 8, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Patient Monitoring Regulatory/Compliance Abbott st-jude-medical Source Type: news
CytoSorbents touts Refresh trial study data
CytoSorbents (OTC:CTSO) today presented results from the Refresh trial of its CytoSorb blood purification technology, touting that the trial met its safety goals and that treatment reduced toxic inflammatory mediators during complex heart surgery.
Data was presented at the American Association for Thoracic Surgery’s centennial conference in Boston this week.
The Monmouth Junction, N.J.-based company’s CytoSorb is an extracorporeal cytokine filter, made up of biocompatible, porous polymer beads that use pore capture and surface adsorption to remove toxic substances from the blood and other bodily fluids.
The pr...
Source: Mass Device - May 5, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Clinical Trials CytoSorbents Corp. Source Type: news
Stable blood sugar linked to heart stent outcomes
Patients with type 2 diabetes and a coronary stent are at lower risk for heart attack and stroke if they maintain good blood sugar control, according to a recent study.
“Although intensive glucose control had no benefit on the rate of major cardiovascular events in previous studies, our data suggest that strict glucose control after PCI (heart catheterization) can improve long-term clinical outcomes in diabetic patients,” Dr. Joo-Yong Hahn from Samsung Medical Center in Seoul said in an interview with Reuters Health.
Researchers looked at 980 patients with type 2 diabetes and a stent, examining long-term bloo...
Source: Mass Device - April 21, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Diabetes Stents Source Type: news
MassDevice.com +5 | The top 5 medtech stories for April 19, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Intuitive Surgical shares rise on solid Q1 beat
Shares in Intuitive Surgical rose today in after-hours trading after the robotic surgical platform maker posted 1st quarter earnings that beat expectations on the Street.
The Sunn...
Source: Mass Device - April 19, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Aspect Imaging raises $30m
MRI maker Aspect Imaging has raised $30 million in a new round of financing, according to VC & equity site Finsmes.
Funding from the round will go to support the development of its Embrace Neonatal MRI system and a newer, stroke-dedicated MRI system, the Israel-based company said.
Aspect Imaging did not release details on the investors in the round, according to the report.
The company, founded in 2003, has raised a total of $150 million, with $20 million coming from a round last year.
In April 2013, the FDA cleared Aspect Imaging’s compact M2 MRI system designed for in-place wrist imaging without a shielded room.
Th...
Source: Mass Device - April 18, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Imaging Aspect Imaging Source Type: news
Organovo CEO Murphy steps away, Crouch steps up | Personnel Moves – April 14, 2017
Organovo (PINK:ONVO) said earlier this week that Taylor Crouch has been appointed as CEO, replacing Keith Murphy who is stepping away from the company. The changes are slated to go into effect on April 21.
Prior to being tapped for the corner office, Crouch operated as CEO of investigative clinical research company eStudySite, the San Diego, Calif.-based company said.
“I am extremely proud of the progress we have made in the last ten years achieving our vision for Organovo. Our 3D bioprinted human tissues are a disruptive and game-changing technology. Founding Organovo and guiding us to our leadership position...
Source: Mass Device - April 14, 2017 Category: Medical Equipment Authors: MassDevice staff Tags: Business/Financial News Active Implants AdvaMed Alphatec Holdings Inc. Anika Therapeutics Inc. Apollo Endosurgery Aurora Spine Baxter Biocorp Biogen Idec Biolase Technology Inc Bioventus LLC Bonesupport Clal Biotech Delcath Sys Source Type: news
Japanese automakers get in on health robotics
ReWalk Robotics
Japanese automakers, including Toyota (NSDQ:ADR), are reportedly turning their focus to robots to help the country’s rapidly aging society.
Japan faces dwindling demand for cars and its falling population has yielded labor shortages and pension squeezes. Toyota today launched a rental service for its walk assist system, which helps stroke survivors learn how to walk again.
Get the full story at our sister site, Medical Design & Outsourcing.
The post Japanese automakers get in on health robotics appeared first on MassDevice.
Source: Mass Device - April 12, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Robotics Toyota Source Type: news
MassDevice.com +5 | The top 5 medtech stories for April 11, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Stimwave wins Australian regulatory nod for Freedom SCS
Stimwave Technologies said late last week it won approval from the Australian Therapeutic Goods Administration for its Freedom spinal cord stimulation system, and launched ...
Source: Mass Device - April 11, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Codman Neuro acquires Neuravi
Johnson & Johnson (NYSE:JNJ) business unit Codman Neuro said today it acquired Neuravi and its portfolio of neurovascular therapy technology for an undisclosed amount.
Neuravi produces the EmboTrap and EmboTrap II revascularization platforms designed capture clots and allow blood flow to resume immediately after the clot has been secured in patients who have experienced a stroke.
J&J’s Codman Neuro said that the acquisition, along with its recent Pulsar Vascular buy, demonstrates the company’s “strong commitment to delivering innovative products for stroke therapy,” according to a press ...
Source: Mass Device - April 10, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Neurological Codman Neuro Neuravi Limited Source Type: news
Neural Analytics raises $10m
Updated to include new information from neural analytics.
Neural Analytics raised $10.1 million in a new round of equity and options financing, according to an SEC filing posted this week.
The Los Angeles-based company develops the Lucid M1, a portable all-in-one ultrasound system designed for rapid triaging and monitoring of patients with brain disorders.
Neural Analytic’s system is a battery operated medical grade tablet device which uses transcranial doppler to assess the brains blood vessels from outside the body. Analyses with the system can be performed in office and can help diagnose brain disorders and avoid mor...
Source: Mass Device - April 10, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological Ultrasound Neural Analytics Source Type: news
ISHLT 2017: Medtronic HVAD trial misses primary endpoint, reports lowered stroke rates
Medtronic (NYSE:MDT) said today that results from the Endurance supplemental trial of its HVAD heart pump system did not meet its primary endpoint, but did report lowered stroke rates compared to standard treatment.
The trial aimed to evaluate the use of the HVAD system, which it picked up along with HeartWare last year, as a destination therapy for patients who require a left ventricular assist device and received improved blood pressure management, the Fridley, Minn.-based company said.
Data from the study was presented at the 2017 International Society for Heart and Lung Transplantation Scientific Meeting in San Dieg...
Source: Mass Device - April 5, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Assist Devices Cardiovascular Clinical Trials HeartWare International Inc. Medtronic Source Type: news
Nico wins CE Mark for BrainPath
Nico Corp said today it won CE Mark approval in the European Union for its BrainPath neurosurgery access device.
The BrainPath system uses a shunt and specially designed instrumentation to give surgeons access to the subcortical section of the brain.
“Gaining CE Mark approval for BrainPath is our first step in answering increasing global interest in a systems approach to subcortical brain surgery using a standardized approach. We intend to take a planned approach to global expansion and look forward to making a positive difference in the worldwide brain tumor and stroke incidence rate,” CEO Jim Pearson said i...
Source: Mass Device - April 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Neurological Regulatory/Compliance Surgical Nico Corp. Source Type: news
